Shattuck Labs, Inc.

XNASHealth care

Last traded price · USD

$5.15

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $5.15
Volume: —
Day's high: —
Day's low: —

In brief

Shattuck Labs, Inc. is a health care company listed on Nasdaq, valued at about $517M.
Its shares closed at $5.15 on 4 Nov 2026, up 166.8% over the past year.
From India you can buy STTK in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Shattuck Labs, Inc. (STTK) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole STTK share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade STTK options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: −12.1% (SPY −1.6%, XLV +13.5%). 3 months: −30.1% (SPY −0.4%, XLV +15.5%). 1 year: +166.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: STTK, SPY and XLV · as of 4 Nov 2026
7.2 days to cover short interest
10.4M shares were sold short at the 15 Oct 2026 settlement, 10.4% of the 100.4M shares outstanding; covering them would take 7.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $5.15 was 16.0% below its 50-day average ($6.13) and 14.8% below its 200-day average ($6.05). It has closed below the 200-day for 17 sessions, since 13 Oct 2026. The 50-day average crossed above the 200-day on 19 Sep 2025, 283 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
52% of the way up its 52-week range
Closed at $5.15 on 4 Nov 2026: 38.2% below the 52-week high of $8.33 (20 Apr 2026) and 199.4% above the low of $1.72 (14 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−12.1%

6 months−22.9%

1 year+166.8%

5 years−72.9%

Newswire

About

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Website

Notable moves

April 7, 2025
+77.35%
October 1, 2024
−44.99%
December 13, 2023
+130.33%

Newswire

About

Website

Notable moves

April 7, 2025
+77.35%
October 1, 2024
−44.99%
December 13, 2023
+130.33%

Shattuck Labs, Inc.

XNASHealth care

Last traded price · USD

$5.15

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $5.15
Volume: —
Day's high: —
Day's low: —

In brief

Shattuck Labs, Inc. is a health care company listed on Nasdaq, valued at about $517M.
Its shares closed at $5.15 on 4 Nov 2026, up 166.8% over the past year.
From India you can buy STTK in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Shattuck Labs, Inc. (STTK) shares from India?

Do I need the price of a whole STTK share to invest?

How much can I invest in US stocks in a year?

Can I trade STTK options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: −12.1% (SPY −1.6%, XLV +13.5%). 3 months: −30.1% (SPY −0.4%, XLV +15.5%). 1 year: +166.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: STTK, SPY and XLV · as of 4 Nov 2026
7.2 days to cover short interest
10.4M shares were sold short at the 15 Oct 2026 settlement, 10.4% of the 100.4M shares outstanding; covering them would take 7.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $5.15 was 16.0% below its 50-day average ($6.13) and 14.8% below its 200-day average ($6.05). It has closed below the 200-day for 17 sessions, since 13 Oct 2026. The 50-day average crossed above the 200-day on 19 Sep 2025, 283 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
52% of the way up its 52-week range
Closed at $5.15 on 4 Nov 2026: 38.2% below the 52-week high of $8.33 (20 Apr 2026) and 199.4% above the low of $1.72 (14 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−12.1%

6 months−22.9%

1 year+166.8%

5 years−72.9%

Newswire

About

Website

Notable moves

April 7, 2025
+77.35%
October 1, 2024
−44.99%
December 13, 2023
+130.33%

Newswire

About

Website

Notable moves

April 7, 2025
+77.35%
October 1, 2024
−44.99%
December 13, 2023
+130.33%

Shattuck Labs, Inc.

Shattuck Labs, Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

7.2 days to cover short interest

Below its 50- and 200-day averages

52% of the way up its 52-week range

Shattuck Labs, Inc.

Shattuck Labs, Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

7.2 days to cover short interest

Below its 50- and 200-day averages

52% of the way up its 52-week range